HALE DAVID F

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
HALE DAVID F's trades of Oncternal Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-27 2024-02-23
B Purchase
43,581 +9.0%
345.89
US$3,432,795 		43,581 +9.0% 345.89 US$3,432,795
2024-02-27 2024-02-23
B Purchase
36,484 -31.5%
252.58
US$3,628,441 		36,484 -31.5% 252.58 US$3,628,441
2021-12-10 2021-12-09
US Biocept Inc (BIOC)
S Sale
98,623 +27.3%
215.58
US$1,640,872 		98,623 +27.3% 215.58 US$1,640,872
2021-12-10 2021-12-09
US Biocept Inc (BIOC)
S Sale
11 -9.8%
4.07
US$45 		11 -9.8% 4.07 US$45
2021-12-10 2021-12-09
US Biocept Inc (BIOC)
S Sale
363 -10.4%
4.06
US$1,474 		363 -10.4% 4.06 US$1,474
2020-06-12 2020-06-12
US Biocept Inc (BIOC)
S Sale
556 -39.1%
0.56
US$309 		556 -39.1% 0.56 US$309
2020-06-12 2020-06-12
US Biocept Inc (BIOC)
S Sale
445 -79.9%
0.55
US$247 		445 -79.9% 0.55 US$247
2020-06-12 2020-06-12
US Biocept Inc (BIOC)
S Sale
159 -4.4%
0.56
US$89 		159 -4.4% 0.56 US$89
2020-05-22 2020-05-21
B Purchase
17,412
0.00
US$0 		17,412 0.00 US$0